Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo

PHASE2CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

January 13, 2023

Study Completion Date

August 29, 2023

Conditions
Non-Segmental Vitiligo
Interventions
DRUG

Upadacitinib

Oral tablets

DRUG

Placebo

Oral tablets

Trial Locations (35)

23502

Virginia Clinical Research, Inc. /ID# 228050, Norfolk

29425

Duplicate_Medical University of South Carolina /ID# 228067, Charleston

31400

CHU Toulouse - Hopital Larrey /ID# 228196, Toulouse

32073

Park Avenue Dermatology, PA /ID# 229400, Orange Park

33075

Duplicate_Hopital Saint-Andre /ID# 228193, Bordeaux

33428

Clearlyderm Dermatology /ID# 227993, Boca Raton

43215

Remington-Davis Clinical Research /ID# 229401, Columbus

46256

Dawes Fretzin, LLC /ID# 227996, Indianapolis

48059

Hamzavi Dermatology /ID# 228056, Fort Gratiot

48346

Duplicate_Michigan Center for Research Company /ID# 228054, Clarkston

69003

HCL - Hopital Edouard Herriot /ID# 228194, Lyon

77401

Bellaire Dermatology Associates /ID# 228004, Bellaire

94000

Duplicate_Hopital Henri Mondor /ID# 228198, Créteil

94063

Stanford University /ID# 228000, Redwood City

97210

Oregon Dermatology and Research Center /ID# 228007, Portland

97223

Oregon Medical Research Center /ID# 228073, Portland

92697-1385

University of California Irvine /ID# 229390, Irvine

33165-3372

New Horizon Research Center /ID# 229403, Miami

33613-1244

ForCare Clinical Research /ID# 228010, Tampa

02111-1552

Tufts Medical Center /ID# 228087, Boston

01655

Duplicate_UMass Chan Medical School /ID# 228066, Worcester

74137-2842

Essential Medical Research, LLC /ID# 228074, Tulsa

37130-2450

International Clinical Research - Tennessee LLC /ID# 228059, Murfreesboro

77030-1501

University of Texas Health Science Center at Houston /ID# 229399, Houston

V3R 6A7

Dr. Chih-ho Hong Medical Inc. /ID# 228403, Surrey

R3M 3Z4

Wiseman Dermatology Research /ID# 228410, Winnipeg

M4W 2N4

Research Toronto /ID# 228401, Toronto

N2J 1C4

Duplicate_K. Papp Clinical Research /ID# 228877, Waterloo

G1V 4X7

Centre de Recherche dermatologique du Quebec Metropolitain /ID# 228388, Québec

06200

Chu de Nice-Hopital Larchet Ii /Id# 228192, Nice

467-8602

Nagoya City University Hospital /ID# 228725, Nagoya

113-8602

Nippon Medical School Hospital /ID# 230361, Bunkyo-ku

160-0023

Tokyo Medical University Hospital /ID# 230288, Shinjuku-ku

990-9585

Yamagata University Hospital /ID# 230362, Yamagata

400-8506

Yamanashi Prefectural Central Hospital /ID# 229441, Kofu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY